Choriomon Amp

Choriomon Amp

Description:

Choriomon Amp (choriomon 5000 i.u. i.m. vial) is a prescription hormonal medicine containing human chorionic gonadotrophin (hCG). It is used under medical supervision in fertility treatment and certain male endocrine disorders. As an injectable gonadotropin, Choriomon mimics the action of luteinizing hormone (LH), supporting ovulation in women and stimulating testicular function in males. This product is intended for intramuscular administration only and must be used exactly as directed by a fertility specialist or endocrinologist.

Indications:

• Female infertility – ovulation induction after carefully monitored follicular stimulation with human menopausal gonadotrophins (hmg) or clomiphene citrate.
• Support of the luteal phase in assisted reproductive techniques as directed by a specialist (where applicable and per local protocol).
• Male cryptorchidism (undescended testes) not due to anatomical obstruction – as part of hormonal therapy.
• Diagnostic aid in cryptorchidism to help determine the need for surgery.
• Pre‑operative use in cryptorchidism to increase testicular size and cord length, facilitating surgical procedure.

Active Ingredients / Key Components:

• Human chorionic gonadotrophin (hcg) – 5000 iu per vial (concentration per ml after reconstitution depends on supplied solvent volume; exact concentration is not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.)).
• Excipients: specific excipients, diluent composition, and preservative content , please check the product leaflet or the manufacturer’s official website. Refer to the official package insert for full excipient list.

Dosage & Administration / How to Use:

• Choriomon Amp is for intramuscular injection only and must be administered by a healthcare professional or under strict medical guidance.
• Female ovulation induction: the exact dose, timing, and number of injections are determined individually by the treating physician, usually given after adequate follicular development with hmg or clomiphene citrate. Typical regimens may involve a single hcg injection timed 24–48 hours after the last stimulation dose, but the precise schedule must follow the doctor’s protocol.
• Male cryptorchidism: dosage, frequency (for example several injections per week over a defined period), and total duration of treatment are individualized based on age, testicular position, and clinical response. Only the treating specialist should set the regimen.
• Reconstitution: the powder in the vial must be dissolved with the supplied solvent according to the package instructions. Gently swirl to dissolve; do not shake vigorously. Use only clear, particle‑free solution.
• Administration: inject slowly intramuscularly using aseptic technique. Do not administer intravenously unless specifically allowed by the official product information.
• Missed dose: if a dose is missed, contact the treating physician for instructions. Do not double the dose without medical advice.
• Use only under close medical supervision with appropriate monitoring (e.g., ultrasound and hormone levels in fertility treatment).

Clinical Benefits:

• Stimulates final follicular maturation and ovulation in women undergoing fertility treatment.
• Supports luteal function by mimicking luteinizing hormone activity, helping maintain progesterone production when indicated.
• Promotes testicular descent and growth in selected cases of cryptorchidism not due to anatomical obstruction.
• Assists in the diagnostic evaluation of undescended testes and may facilitate subsequent surgical correction by increasing testicular size and cord length.

Warnings & Contraindications:

• Use only under the supervision of a specialist experienced in fertility or endocrine therapy.
• Contraindicated in known hypersensitivity to human chorionic gonadotrophin or any component of the formulation.
• Contraindicated in hormone‑dependent tumors such as androgen‑dependent carcinoma of the prostate or breast carcinoma in males, and in estrogen‑ or progesterone‑dependent malignancies in females where hcg use is not appropriate.
• Not to be used in pregnancy except where specifically indicated by a specialist; usually contraindicated once pregnancy is established.
• Use with extreme caution in patients at risk of ovarian hyperstimulation syndrome (ohss), polycystic ovary syndrome (pcos), or with enlarged ovaries. Discontinue stimulation and withhold hcg if excessive ovarian response is suspected.
• Risk of multiple pregnancy and ectopic pregnancy in fertility treatments; careful monitoring is required.
• Caution in patients with uncontrolled thyroid or adrenal disorders, cardiac disease, epilepsy, migraine, or renal impairment; consult a specialist before use.
• May interfere with pregnancy tests by causing false‑positive results due to exogenous hcg.
• Consult your doctor before use if pregnant, nursing, taking other hormonal medications, or have medical conditions such as hormone‑dependent cancers, severe liver disease, kidney disease, or thromboembolic disorders.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.
• Do not use if the vial is damaged, the solution after reconstitution is cloudy or contains particles, or if the product is past its expiry date.

Side Effects:

• Common side effects: local injection site reactions (pain, redness, swelling), headache, fatigue, mood changes, irritability, or mild abdominal discomfort.
• In women: risk of ovarian hyperstimulation syndrome (ohss) with symptoms such as severe pelvic/abdominal pain, rapid weight gain, nausea, vomiting, diarrhea, shortness of breath, or decreased urine output. Seek urgent medical attention if these occur.
• Increased risk of multiple pregnancy (twins or more) and, rarely, thromboembolic events in the context of fertility treatment.
• In men and boys: possible gynecomastia (breast enlargement), acne, fluid retention, mood changes, or early signs of puberty in prepubertal boys.
• Allergic reactions: rash, itching, swelling of face/lips/tongue, severe dizziness, or difficulty breathing require immediate medical attention.
• Any unexpected, persistent, or severe side effects should be reported promptly to the treating physician.

Storage Instructions:

Store in a cool, dry place away from direct sunlight. Keep container tightly closed. Keep out of reach of children. Follow the storage temperature indicated on the outer carton (commonly refrigerated or below a specified temperature; exact range is not available in the provided information). Do not freeze unless the official leaflet allows it. Use immediately after reconstitution or within the time frame specified in the package insert; discard any unused solution safely.

Specifications:

• Form: powder for solution for injection in vial, to be used with supplied solvent for intramuscular administration.
• Strength: 5000 iu human chorionic gonadotrophin per vial.
• Pack size: number of vials and solvent ampoules per pack is not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.); refer to the product packaging.
• Route of administration: intramuscular injection.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.